Webinar | TiO₂ alternatives for food, pharma, and personal care Register Here

Mable (Neurolytic Healthcare)

Genomics based individualized care for people with neurological conditions.
2019
11-50
Oxford, Oxfordshire, United Kingdom
Health CareMedicalNeurosciencePrecision Medicine

Investment Funding

Last Funding Stage

Seed

Total Funding Amount

3.25M

Last Funding Amount

3.2M

Last Funding Date

27-07-2022

Startup Stage

Seed

Lead Investors

Y Combinator, Initialized Capital, Illumina, Creative Destruction Lab (CDL), Arkitekt Ventures

Revenue

$1M to $10M

People

Founders